ACSL4 and renal cell carcinoma: In summary, this study elucidates a novel pathogenic mechanism in RCC by demonstrating that the E3 ubiquitin ligase COP1 directly interacts with ACSL4 and promotes its K48-linked ubiquitination and proteasomal degradation.